Yoshikawa, M., Nakayamada, S., Kubo, S., Nawata, A., Kitanaga, Y., Iwata, S., . . . Tanaka, Y. (2019). Type I and II interferons commit to abnormal expression of chemokine receptor on B cells in patients with systemic lupus erythematosus. Clinical immunology (Orlando, Fla.), 200, 1. https://doi.org/10.1016/j.clim.2018.12.017
Style de citation ChicagoYoshikawa, Maiko, et al. "Type I and II Interferons Commit to Abnormal Expression of Chemokine Receptor on B Cells in Patients with Systemic Lupus Erythematosus." Clinical Immunology (Orlando, Fla.) 200 (2019): 1. https://dx.doi.org/10.1016/j.clim.2018.12.017.
Style de citation MLAYoshikawa, Maiko, et al. "Type I and II Interferons Commit to Abnormal Expression of Chemokine Receptor on B Cells in Patients with Systemic Lupus Erythematosus." Clinical Immunology (Orlando, Fla.), vol. 200, 2019, p. 1.